Results summary | View all lists in L2L MDB | View all genes in C01A.profile.u50 |
Down-regulated at least 1.4-fold following treatment of MCF-7 human breast carcinoma cells with non-carcinogenic benzo(e)pyrene (BeP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 47.59-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
200797_S_AT | MCL1 | G | D | S | ![]() |
![]() |
myeloid cell leukemia sequence 1 (BCL2-related) | ||||||
201694_S_AT | EGR1 | D | R | ![]() |
![]() |
early growth response 1 | |||||||
201693_S_AT | EGR1 | D | R | ![]() |
![]() |
early growth response 1 | |||||||
209189_AT | FOS | D | X | R | ![]() |
![]() |
v-fos FBJ murine osteosarcoma viral oncogene homolog |